Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXK1
|
ENSG00000164916.9 | FOXK1 |
FOXP2
|
ENSG00000128573.18 | FOXP2 |
FOXB1
|
ENSG00000171956.5 | FOXB1 |
FOXP3
|
ENSG00000049768.10 | FOXP3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
FOXB1 | chr15_60296272_60296423 | 74 | 0.986034 | -0.76 | 1.7e-02 | Click! |
FOXB1 | chr15_60296550_60297023 | 365 | 0.928800 | -0.68 | 4.6e-02 | Click! |
FOXB1 | chr15_60297915_60298086 | 1579 | 0.549305 | -0.63 | 6.9e-02 | Click! |
FOXB1 | chr15_60289534_60289829 | 6740 | 0.321002 | -0.63 | 6.9e-02 | Click! |
FOXB1 | chr15_60297607_60297758 | 1261 | 0.623491 | -0.60 | 8.7e-02 | Click! |
FOXK1 | chr7_4784738_4785028 | 4393 | 0.203799 | -0.71 | 3.4e-02 | Click! |
FOXK1 | chr7_4681559_4681752 | 1733 | 0.443302 | -0.70 | 3.7e-02 | Click! |
FOXK1 | chr7_4784274_4784732 | 4013 | 0.210404 | -0.66 | 5.1e-02 | Click! |
FOXK1 | chr7_4785133_4785293 | 4723 | 0.199142 | -0.63 | 6.9e-02 | Click! |
FOXK1 | chr7_4721445_4721681 | 377 | 0.877057 | -0.61 | 8.4e-02 | Click! |
FOXP2 | chr7_114142745_114143065 | 76335 | 0.100211 | 0.70 | 3.5e-02 | Click! |
FOXP2 | chr7_113747562_113747713 | 21022 | 0.235910 | 0.67 | 4.7e-02 | Click! |
FOXP2 | chr7_114055046_114055222 | 21 | 0.983080 | 0.65 | 5.7e-02 | Click! |
FOXP2 | chr7_113722711_113723554 | 3483 | 0.303350 | 0.65 | 6.0e-02 | Click! |
FOXP2 | chr7_114055343_114055580 | 83 | 0.978264 | 0.61 | 7.8e-02 | Click! |
FOXP3 | chrX_49120810_49120961 | 403 | 0.701544 | -0.43 | 2.4e-01 | Click! |
FOXP3 | chrX_49116228_49116379 | 606 | 0.538456 | -0.34 | 3.7e-01 | Click! |
FOXP3 | chrX_49116470_49116621 | 848 | 0.396715 | -0.34 | 3.7e-01 | Click! |
FOXP3 | chrX_49117374_49117525 | 1752 | 0.186217 | -0.32 | 4.1e-01 | Click! |
FOXP3 | chrX_49120475_49120626 | 738 | 0.453583 | -0.24 | 5.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_77380232_77380598 | 2.52 |
CTDP1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
59386 |
0.13 |
chr3_167811230_167811432 | 2.11 |
GOLIM4 |
golgi integral membrane protein 4 |
1801 |
0.51 |
chr3_46607065_46607798 | 1.63 |
LRRC2 |
leucine rich repeat containing 2 |
609 |
0.64 |
chr1_183841636_183841838 | 1.53 |
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1 |
67447 |
0.11 |
chr4_81195528_81195918 | 1.50 |
FGF5 |
fibroblast growth factor 5 |
7930 |
0.26 |
chr13_36048764_36048946 | 1.44 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
1977 |
0.3 |
chr15_49717786_49717937 | 1.40 |
FGF7 |
fibroblast growth factor 7 |
2404 |
0.35 |
chr16_55513844_55514378 | 1.38 |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
201 |
0.95 |
chr16_4422135_4423224 | 1.38 |
VASN |
vasorin |
830 |
0.49 |
chr6_81938853_81939008 | 1.38 |
RP1-300G12.2 |
|
305700 |
0.01 |
chr18_32290997_32291170 | 1.36 |
DTNA |
dystrobrevin, alpha |
822 |
0.73 |
chr1_98514742_98514981 | 1.34 |
ENSG00000225206 |
. |
3134 |
0.4 |
chr4_176922498_176923243 | 1.33 |
GPM6A |
glycoprotein M6A |
613 |
0.78 |
chr5_78858614_78858786 | 1.33 |
ENSG00000207391 |
. |
28024 |
0.18 |
chr1_172110530_172111247 | 1.32 |
ENSG00000207949 |
. |
2841 |
0.22 |
chr8_6419657_6419902 | 1.29 |
ANGPT2 |
angiopoietin 2 |
786 |
0.74 |
chr9_18476160_18476529 | 1.29 |
ADAMTSL1 |
ADAMTS-like 1 |
2113 |
0.45 |
chr18_77379773_77379948 | 1.26 |
CTDP1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
59941 |
0.13 |
chr2_163099011_163099583 | 1.24 |
FAP |
fibroblast activation protein, alpha |
261 |
0.94 |
chr4_81392876_81393298 | 1.24 |
C4orf22 |
chromosome 4 open reading frame 22 |
136164 |
0.05 |
chr2_230035602_230035855 | 1.22 |
PID1 |
phosphotyrosine interaction domain containing 1 |
61073 |
0.14 |
chr1_61668583_61669016 | 1.21 |
RP4-802A10.1 |
|
78394 |
0.11 |
chr2_20297865_20298016 | 1.20 |
RP11-644K8.1 |
|
46045 |
0.11 |
chr1_172154318_172154604 | 1.18 |
DNM3OS |
DNM3 opposite strand/antisense RNA |
40527 |
0.14 |
chr18_77378799_77378950 | 1.17 |
CTDP1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
60927 |
0.13 |
chr1_246750885_246751091 | 1.17 |
RP11-439E19.1 |
|
18187 |
0.16 |
chr13_27159304_27159456 | 1.17 |
WASF3 |
WAS protein family, member 3 |
27493 |
0.23 |
chr16_86542600_86543872 | 1.16 |
FOXF1 |
forkhead box F1 |
897 |
0.62 |
chr6_125698814_125699135 | 1.15 |
RP11-735G4.1 |
|
3504 |
0.35 |
chr1_85826637_85826852 | 1.14 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
43436 |
0.13 |
chr3_73671180_73671369 | 1.13 |
PDZRN3-AS1 |
PDZRN3 antisense RNA 1 |
410 |
0.85 |
chr18_67067700_67067896 | 1.11 |
DOK6 |
docking protein 6 |
493 |
0.89 |
chr14_29228686_29229081 | 1.10 |
RP11-966I7.1 |
|
5586 |
0.17 |
chr6_116833589_116833880 | 1.10 |
TRAPPC3L |
trafficking protein particle complex 3-like |
228 |
0.83 |
chr18_57363476_57363657 | 1.09 |
RP11-2N1.2 |
|
125 |
0.93 |
chr7_39497957_39498302 | 1.07 |
POU6F2-AS1 |
POU6F2 antisense RNA 1 |
52184 |
0.14 |
chr12_91571050_91571576 | 1.07 |
DCN |
decorin |
1016 |
0.66 |
chr2_144692978_144693129 | 1.06 |
AC016910.1 |
|
1587 |
0.49 |
chr17_77767116_77767731 | 1.05 |
CBX8 |
chromobox homolog 8 |
3492 |
0.16 |
chr6_154732154_154732320 | 1.05 |
CNKSR3 |
CNKSR family member 3 |
19392 |
0.25 |
chr2_36924555_36924939 | 1.04 |
VIT |
vitrin |
727 |
0.75 |
chr5_155754238_155754771 | 1.04 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
737 |
0.81 |
chr21_17677767_17678526 | 1.03 |
ENSG00000201025 |
. |
21057 |
0.28 |
chr6_56707059_56707245 | 1.02 |
DST |
dystonin |
791 |
0.6 |
chr18_77378602_77378753 | 1.01 |
CTDP1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
61124 |
0.13 |
chr15_96883311_96883827 | 1.01 |
ENSG00000222651 |
. |
7079 |
0.16 |
chr1_244012088_244013269 | 1.01 |
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
752 |
0.75 |
chr18_8707466_8707765 | 1.00 |
RP11-674N23.1 |
|
4 |
0.73 |
chr8_15398472_15398721 | 1.00 |
TUSC3 |
tumor suppressor candidate 3 |
804 |
0.72 |
chr6_19691587_19692480 | 1.00 |
ENSG00000200957 |
. |
49273 |
0.18 |
chr4_15376364_15376854 | 0.99 |
C1QTNF7 |
C1q and tumor necrosis factor related protein 7 |
434 |
0.86 |
chr3_71293724_71294002 | 0.99 |
FOXP1 |
forkhead box P1 |
453 |
0.89 |
chr6_148829582_148830289 | 0.99 |
ENSG00000223322 |
. |
15441 |
0.29 |
chr4_175075425_175075781 | 0.99 |
FBXO8 |
F-box protein 8 |
129211 |
0.05 |
chr9_118918844_118919316 | 0.99 |
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
2997 |
0.34 |
chr6_56706635_56706858 | 0.98 |
DST |
dystonin |
1197 |
0.47 |
chr1_115397478_115398199 | 0.98 |
SYCP1 |
synaptonemal complex protein 1 |
84 |
0.98 |
chr15_64231749_64232239 | 0.97 |
RP11-111E14.1 |
|
11521 |
0.22 |
chr1_193152957_193153118 | 0.97 |
B3GALT2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
2747 |
0.29 |
chr4_157890835_157890986 | 0.97 |
PDGFC |
platelet derived growth factor C |
1145 |
0.55 |
chr4_138450639_138450790 | 0.96 |
PCDH18 |
protocadherin 18 |
2851 |
0.43 |
chr4_81193832_81194058 | 0.96 |
FGF5 |
fibroblast growth factor 5 |
6152 |
0.26 |
chr4_81192543_81192855 | 0.95 |
FGF5 |
fibroblast growth factor 5 |
4906 |
0.28 |
chr6_155475558_155475911 | 0.95 |
TIAM2 |
T-cell lymphoma invasion and metastasis 2 |
5479 |
0.3 |
chr6_19465542_19465832 | 0.95 |
ENSG00000201523 |
. |
27173 |
0.27 |
chr7_66532196_66532424 | 0.95 |
ENSG00000266525 |
. |
47074 |
0.12 |
chr13_114468657_114468808 | 0.93 |
TMEM255B |
transmembrane protein 255B |
2377 |
0.35 |
chr7_115912354_115912783 | 0.92 |
TES |
testis derived transcript (3 LIM domains) |
22079 |
0.19 |
chr6_148664293_148664728 | 0.92 |
SASH1 |
SAM and SH3 domain containing 1 |
781 |
0.74 |
chr8_92612283_92612746 | 0.91 |
ENSG00000200151 |
. |
5321 |
0.33 |
chr6_148831295_148831530 | 0.91 |
ENSG00000223322 |
. |
13964 |
0.3 |
chr1_222258695_222259045 | 0.91 |
ENSG00000212094 |
. |
72438 |
0.13 |
chr12_27933175_27934389 | 0.90 |
KLHL42 |
kelch-like family member 42 |
18 |
0.73 |
chr5_72742132_72742882 | 0.89 |
FOXD1 |
forkhead box D1 |
1845 |
0.37 |
chr11_85429273_85429899 | 0.89 |
SYTL2 |
synaptotagmin-like 2 |
55 |
0.97 |
chr7_92324656_92325109 | 0.88 |
ENSG00000206763 |
. |
6246 |
0.27 |
chr21_17910454_17910605 | 0.88 |
ENSG00000207638 |
. |
880 |
0.55 |
chr1_224808626_224808777 | 0.88 |
CNIH3 |
cornichon family AMPA receptor auxiliary protein 3 |
4706 |
0.23 |
chr7_72209303_72209642 | 0.88 |
TYW1B |
tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae) |
253 |
0.92 |
chr8_80268388_80268539 | 0.87 |
STMN2 |
stathmin-like 2 |
254586 |
0.02 |
chr8_118993051_118993436 | 0.87 |
EXT1 |
exostosin glycosyltransferase 1 |
129410 |
0.06 |
chr10_49811984_49812175 | 0.87 |
ARHGAP22 |
Rho GTPase activating protein 22 |
918 |
0.63 |
chr19_13137194_13137536 | 0.86 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1554 |
0.23 |
chr11_101982396_101983287 | 0.86 |
YAP1 |
Yes-associated protein 1 |
404 |
0.82 |
chr10_17391082_17391289 | 0.86 |
ST8SIA6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
22077 |
0.18 |
chr2_150418995_150419256 | 0.86 |
AC144449.1 |
|
24585 |
0.19 |
chr6_167764253_167765165 | 0.86 |
TTLL2 |
tubulin tyrosine ligase-like family, member 2 |
26135 |
0.18 |
chr21_28337586_28337737 | 0.86 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
1171 |
0.55 |
chr2_134325837_134326056 | 0.86 |
NCKAP5 |
NCK-associated protein 5 |
85 |
0.98 |
chr1_93342801_93342952 | 0.86 |
ENSG00000207022 |
. |
31260 |
0.1 |
chr6_45523679_45523878 | 0.86 |
ENSG00000252738 |
. |
90063 |
0.09 |
chr2_189843684_189844024 | 0.85 |
ENSG00000221502 |
. |
1036 |
0.57 |
chr5_158438402_158438767 | 0.85 |
CTD-2363C16.2 |
|
25770 |
0.2 |
chr11_121970307_121971111 | 0.84 |
ENSG00000207971 |
. |
157 |
0.79 |
chr7_130132965_130133179 | 0.84 |
MEST |
mesoderm specific transcript |
759 |
0.48 |
chr6_56555918_56556226 | 0.84 |
DST |
dystonin |
48278 |
0.18 |
chr7_147110177_147110568 | 0.84 |
ENSG00000221442 |
. |
35159 |
0.24 |
chr12_47984663_47984814 | 0.84 |
RPAP3 |
RNA polymerase II associated protein 3 |
115031 |
0.05 |
chr5_122621557_122621723 | 0.84 |
CEP120 |
centrosomal protein 120kDa |
137357 |
0.05 |
chr2_197852125_197852688 | 0.84 |
ANKRD44 |
ankyrin repeat domain 44 |
12820 |
0.25 |
chr1_78959562_78959713 | 0.84 |
PTGFR |
prostaglandin F receptor (FP) |
2880 |
0.37 |
chr9_110513848_110514093 | 0.83 |
AL162389.1 |
Uncharacterized protein |
26449 |
0.19 |
chr1_101754265_101754416 | 0.83 |
RP4-575N6.5 |
|
45626 |
0.13 |
chr1_63155545_63155718 | 0.83 |
RP11-230B22.1 |
|
1478 |
0.35 |
chr18_53070691_53070905 | 0.82 |
TCF4 |
transcription factor 4 |
139 |
0.97 |
chr6_27264311_27264507 | 0.82 |
POM121L2 |
POM121 transmembrane nucleoporin-like 2 |
14682 |
0.2 |
chr5_95068939_95069254 | 0.82 |
CTD-2154I11.2 |
|
1097 |
0.44 |
chr4_107234215_107234366 | 0.82 |
AIMP1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
2411 |
0.31 |
chr14_51129406_51129557 | 0.82 |
RP11-248J18.2 |
|
415 |
0.8 |
chr15_96869491_96869741 | 0.82 |
NR2F2 |
nuclear receptor subfamily 2, group F, member 2 |
449 |
0.57 |
chrX_118372355_118372574 | 0.82 |
PGRMC1 |
progesterone receptor membrane component 1 |
2176 |
0.39 |
chr12_50796133_50796284 | 0.81 |
LARP4 |
La ribonucleoprotein domain family, member 4 |
1232 |
0.46 |
chr4_21769993_21770244 | 0.81 |
KCNIP4 |
Kv channel interacting protein 4 |
70721 |
0.12 |
chr12_63025567_63026419 | 0.81 |
ENSG00000238475 |
. |
18962 |
0.14 |
chr18_53068154_53068339 | 0.81 |
TCF4 |
transcription factor 4 |
320 |
0.92 |
chr2_188416841_188416992 | 0.81 |
AC007319.1 |
|
1960 |
0.34 |
chr7_10491465_10491616 | 0.81 |
ENSG00000212422 |
. |
229116 |
0.02 |
chr2_188354408_188354559 | 0.80 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
23885 |
0.21 |
chr6_3825964_3826270 | 0.80 |
RP11-420L9.4 |
|
6050 |
0.22 |
chr3_150131580_150131731 | 0.79 |
TSC22D2 |
TSC22 domain family, member 2 |
2859 |
0.37 |
chr2_67743763_67743914 | 0.79 |
ETAA1 |
Ewing tumor-associated antigen 1 |
119387 |
0.07 |
chr15_56204998_56205389 | 0.79 |
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
2659 |
0.34 |
chr5_87798778_87798945 | 0.79 |
TMEM161B-AS1 |
TMEM161B antisense RNA 1 |
76349 |
0.11 |
chr8_6419385_6419605 | 0.79 |
ANGPT2 |
angiopoietin 2 |
1070 |
0.63 |
chr2_236514640_236514828 | 0.79 |
ENSG00000221704 |
. |
34159 |
0.2 |
chr8_57069618_57070103 | 0.79 |
ENSG00000221093 |
. |
35949 |
0.12 |
chr5_120114861_120115414 | 0.79 |
ENSG00000222609 |
. |
68602 |
0.14 |
chrX_99890951_99891409 | 0.79 |
TSPAN6 |
tetraspanin 6 |
623 |
0.71 |
chr6_151647400_151647551 | 0.79 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
652 |
0.61 |
chr4_105315656_105315807 | 0.78 |
ENSG00000272082 |
. |
96302 |
0.08 |
chr8_120685095_120685496 | 0.78 |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
398 |
0.89 |
chr1_68084153_68084510 | 0.78 |
ENSG00000242482 |
. |
38481 |
0.16 |
chr8_107095391_107095542 | 0.78 |
ENSG00000251003 |
. |
22714 |
0.27 |
chr8_49831086_49831370 | 0.78 |
SNAI2 |
snail family zinc finger 2 |
2760 |
0.41 |
chr7_27217405_27217623 | 0.78 |
RP1-170O19.20 |
Uncharacterized protein |
2118 |
0.1 |
chr4_140822945_140823261 | 0.78 |
MAML3 |
mastermind-like 3 (Drosophila) |
10982 |
0.28 |
chr1_163039219_163039545 | 0.77 |
RGS4 |
regulator of G-protein signaling 4 |
231 |
0.96 |
chr4_2870111_2870324 | 0.77 |
ADD1 |
adducin 1 (alpha) |
7406 |
0.2 |
chr6_44510355_44510599 | 0.77 |
ENSG00000266619 |
. |
107099 |
0.06 |
chr9_13278025_13278176 | 0.77 |
RP11-272P10.2 |
|
1086 |
0.46 |
chr5_141980216_141980760 | 0.77 |
AC005592.2 |
|
19075 |
0.18 |
chr18_52357258_52357685 | 0.77 |
RAB27B |
RAB27B, member RAS oncogene family |
27620 |
0.24 |
chr11_12697523_12698245 | 0.76 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
834 |
0.75 |
chr4_187857953_187858132 | 0.76 |
ENSG00000252382 |
. |
79432 |
0.12 |
chr2_198539523_198539712 | 0.76 |
RFTN2 |
raftlin family member 2 |
1102 |
0.51 |
chr3_114477226_114477377 | 0.76 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
486 |
0.86 |
chr6_56707311_56707814 | 0.76 |
DST |
dystonin |
381 |
0.81 |
chr7_45958576_45958727 | 0.76 |
IGFBP3 |
insulin-like growth factor binding protein 3 |
1626 |
0.39 |
chr4_30727648_30727863 | 0.76 |
PCDH7 |
protocadherin 7 |
3778 |
0.36 |
chrX_19688369_19688923 | 0.76 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
166 |
0.97 |
chr5_92333922_92334106 | 0.76 |
ENSG00000221810 |
. |
280794 |
0.01 |
chr4_173978735_173978902 | 0.76 |
ENSG00000241652 |
. |
83976 |
0.09 |
chr8_99956074_99956225 | 0.76 |
OSR2 |
odd-skipped related transciption factor 2 |
521 |
0.65 |
chr6_104981791_104982069 | 0.76 |
ENSG00000252944 |
. |
232767 |
0.02 |
chr13_38443188_38443573 | 0.75 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
480 |
0.86 |
chr10_112411260_112411724 | 0.75 |
RBM20 |
RNA binding motif protein 20 |
7337 |
0.16 |
chr7_27217679_27217830 | 0.75 |
RP1-170O19.20 |
Uncharacterized protein |
1878 |
0.11 |
chr16_73266705_73266923 | 0.75 |
C16orf47 |
chromosome 16 open reading frame 47 |
88468 |
0.1 |
chr20_10903858_10904074 | 0.75 |
RP11-103J8.1 |
|
21034 |
0.27 |
chr1_158969050_158969253 | 0.75 |
IFI16 |
interferon, gamma-inducible protein 16 |
607 |
0.76 |
chr1_230358064_230358247 | 0.75 |
RP5-956O18.2 |
|
46074 |
0.16 |
chr13_31481253_31481536 | 0.75 |
MEDAG |
mesenteric estrogen-dependent adipogenesis |
551 |
0.78 |
chr6_132076285_132076436 | 0.75 |
ENSG00000266807 |
. |
36952 |
0.12 |
chr13_33803329_33803516 | 0.75 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
23279 |
0.2 |
chr1_59527946_59528115 | 0.75 |
FGGY |
FGGY carbohydrate kinase domain containing |
234280 |
0.02 |
chr7_2842191_2842738 | 0.75 |
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
12428 |
0.25 |
chr5_38550048_38550208 | 0.74 |
LIFR |
leukemia inhibitory factor receptor alpha |
6610 |
0.18 |
chr6_105936563_105936714 | 0.74 |
PREP |
prolyl endopeptidase |
85679 |
0.1 |
chr7_134551561_134551712 | 0.74 |
CALD1 |
caldesmon 1 |
44 |
0.99 |
chr19_45995836_45996758 | 0.74 |
RTN2 |
reticulon 2 |
228 |
0.87 |
chr10_114819322_114819557 | 0.74 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
84240 |
0.1 |
chr2_65593026_65593803 | 0.74 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
370 |
0.89 |
chr14_64663537_64663695 | 0.74 |
SYNE2 |
spectrin repeat containing, nuclear envelope 2 |
5295 |
0.27 |
chr14_53834699_53834850 | 0.74 |
RP11-547D23.1 |
|
214702 |
0.02 |
chr14_27340112_27340410 | 0.74 |
ENSG00000265165 |
. |
37587 |
0.19 |
chr13_74705317_74705609 | 0.74 |
KLF12 |
Kruppel-like factor 12 |
2931 |
0.41 |
chr6_150152266_150152469 | 0.74 |
RP11-350J20.12 |
|
21231 |
0.11 |
chr5_151065704_151066114 | 0.74 |
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
615 |
0.66 |
chr18_7461045_7461265 | 0.74 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
105625 |
0.07 |
chr1_209757611_209757762 | 0.74 |
CAMK1G |
calcium/calmodulin-dependent protein kinase IG |
612 |
0.74 |
chr17_1617409_1617560 | 0.74 |
ENSG00000186594 |
. |
199 |
0.87 |
chr5_158437815_158438054 | 0.73 |
CTD-2363C16.2 |
|
25120 |
0.2 |
chr1_89197420_89197765 | 0.73 |
PKN2 |
protein kinase N2 |
39546 |
0.16 |
chr1_24621056_24621364 | 0.73 |
ENSG00000266511 |
. |
14865 |
0.15 |
chr2_216296000_216296151 | 0.73 |
FN1 |
fibronectin 1 |
4715 |
0.24 |
chr18_56168357_56168508 | 0.73 |
RP11-1151B14.4 |
|
34215 |
0.13 |
chr5_103680813_103681290 | 0.73 |
ENSG00000239808 |
. |
84524 |
0.11 |
chr5_140801311_140801579 | 0.73 |
PCDHGA11 |
protocadherin gamma subfamily A, 11 |
650 |
0.41 |
chr2_61898664_61898946 | 0.73 |
ENSG00000206973 |
. |
66054 |
0.12 |
chr4_123749443_123749605 | 0.73 |
ENSG00000253069 |
. |
1355 |
0.35 |
chr11_47945991_47946142 | 0.73 |
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
56047 |
0.11 |
chr18_56663091_56663242 | 0.72 |
ENSG00000251870 |
. |
69638 |
0.1 |
chr2_188417834_188418053 | 0.72 |
AC007319.1 |
|
933 |
0.47 |
chr6_150176715_150177267 | 0.72 |
RP11-350J20.12 |
|
3393 |
0.15 |
chr2_36598892_36599078 | 0.72 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
15371 |
0.28 |
chr5_71543858_71544009 | 0.72 |
ENSG00000244748 |
. |
66582 |
0.09 |
chr10_95239818_95240064 | 0.72 |
MYOF |
myoferlin |
2010 |
0.32 |
chr2_155001115_155001266 | 0.71 |
ENSG00000266512 |
. |
1530 |
0.54 |
chr2_133998912_133999202 | 0.71 |
AC010890.1 |
|
23483 |
0.24 |
chr1_113999893_114000106 | 0.71 |
MAGI3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
66388 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 2.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.7 | 2.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.6 | 2.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 1.8 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.6 | 1.8 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.5 | 1.4 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 1.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.4 | 0.9 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.4 | 1.7 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 1.6 | GO:0060013 | righting reflex(GO:0060013) |
0.4 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 1.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 1.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 0.7 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.3 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.3 | 1.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 2.3 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 0.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 0.6 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 1.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 0.9 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 1.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.3 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.3 | 0.5 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.3 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.8 | GO:0060242 | contact inhibition(GO:0060242) |
0.3 | 1.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 2.8 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.3 | 0.8 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.3 | 1.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 1.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 1.2 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) regulation of sprouting angiogenesis(GO:1903670) positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 0.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.2 | GO:0072338 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 1.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 1.7 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.2 | 1.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 5.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.2 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.2 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.2 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.2 | 1.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 0.4 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 1.1 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 1.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.8 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.6 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.2 | 0.2 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.2 | 1.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 0.6 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.2 | 0.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 2.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.8 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.4 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.7 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 3.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 1.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.5 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.2 | 0.3 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.2 | 0.3 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 2.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 0.6 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 0.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 1.1 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.2 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 1.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.1 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.3 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.6 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 1.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 2.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 1.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 1.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.1 | GO:2000051 | embryonic retina morphogenesis in camera-type eye(GO:0060059) regulation of non-canonical Wnt signaling pathway(GO:2000050) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.3 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.2 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.4 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 1.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.7 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.9 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.8 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.1 | 1.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.2 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.3 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.4 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.2 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.2 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 2.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.4 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.1 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.1 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.1 | 0.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.2 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.2 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.2 | GO:0051280 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.5 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 1.4 | GO:0014033 | neural crest cell development(GO:0014032) neural crest cell differentiation(GO:0014033) |
0.1 | 0.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:0060439 | trachea morphogenesis(GO:0060439) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.1 | GO:0003308 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:0001880 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.1 | 1.0 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.5 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.3 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 0.3 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.1 | 0.1 | GO:0071803 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.4 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.6 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.5 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.3 | GO:0021988 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.1 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.3 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.4 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.4 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.4 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.1 | 0.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0010092 | specification of organ identity(GO:0010092) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.3 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.2 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.1 | 0.1 | GO:0060740 | prostate gland epithelium morphogenesis(GO:0060740) |
0.1 | 0.4 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.2 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.3 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.2 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.1 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.1 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.4 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.5 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.2 | GO:0043092 | L-amino acid import(GO:0043092) |
0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.1 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.3 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.0 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.4 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.5 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.1 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.0 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) regulation of muscle hypertrophy(GO:0014743) |
0.0 | 5.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.2 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0071072 | regulation of phospholipid biosynthetic process(GO:0071071) negative regulation of phospholipid biosynthetic process(GO:0071072) negative regulation of phospholipid metabolic process(GO:1903726) |
0.0 | 0.0 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.2 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.0 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.6 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0003206 | cardiac chamber morphogenesis(GO:0003206) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.3 | GO:0051588 | regulation of neurotransmitter secretion(GO:0046928) regulation of neurotransmitter transport(GO:0051588) |
0.0 | 0.2 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.9 | GO:0030509 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.0 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.4 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.8 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.0 | 0.2 | GO:0061515 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 0.0 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 3.3 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.1 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.4 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0010269 | response to selenium ion(GO:0010269) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.3 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.3 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.4 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.0 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 1.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.2 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.4 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.2 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.3 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.7 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.3 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.0 | 0.0 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.6 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.0 | 0.0 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.0 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.2 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 0.3 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.0 | 0.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.2 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0003205 | cardiac chamber development(GO:0003205) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.0 | 0.0 | GO:0071675 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.3 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.6 | 1.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 1.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 3.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 1.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 0.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 1.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 2.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.9 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 1.0 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.8 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 1.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.1 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.9 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 1.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.1 | 2.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.9 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 3.2 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 2.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 4.3 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 5.1 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 18.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.9 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 3.2 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 11.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.1 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.3 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 3.3 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 1.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 1.1 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.0 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 12.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.2 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 1.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.0 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.6 | 1.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 1.8 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.4 | 1.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.4 | 1.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 3.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 1.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 3.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.3 | 1.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 1.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 2.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 1.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 7.7 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 1.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 2.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 2.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 1.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 0.5 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.9 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.7 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 1.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 1.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.4 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 2.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 5.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 1.3 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.3 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 1.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.4 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 5.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 1.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 1.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 1.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 8.3 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 2.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.0 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 1.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.5 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 2.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.5 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 1.0 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 7.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 7.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 10.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 2.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 4.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 6.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 6.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 2.1 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.7 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.4 | 3.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 3.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 7.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 4.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 0.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 1.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 1.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 2.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 3.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 4.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 1.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 1.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.7 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 1.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |